{
    "organizations": [],
    "uuid": "601b5525002e8299fd5c759c95b5418182165dd3",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-ose-immunotherapeutics-fy-revenue/brief-ose-immunotherapeutics-fy-revenue-up-at-6-7-million-euros-idUSW8N1A7023",
    "ord_in_thread": 0,
    "title": "BRIEF-Ose Immunotherapeutics FY Revenue Up At 6.7 Million Euros",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 28 (Reuters) - OSE IMMUNOTHERAPEUTICS SA:\n* TEDOPI: REDEPLOYMENT OF THE PHASE 3 CLINICAL PHASE IN EARLY 2018\n* TEDOPI: PHASE 2 TRIAL IN PANCREATIC CANCER INITIATION IS EXPECTED IN 2018\n* OSE-172: ENTRY INTO CLINICAL PHASE PLANNED IN 2018\n* FY OPERATING LOSS EUR 12.6 MILLION VERSUS PROFIT EUR 17.5 MILLION YEAR AGO\n* FY NET LOSS EUR 10.5 MILLION VERSUS PROFIT EUR 20.7 MILLION YEAR AGO\n* CASH AVAILABLE AS OF DECEMBER 31, 2017 OF EUR 12.5 MILLION VERSUS EUR 17.8 MILLION YEAR AGO\n* FY REVENUE EUR 6.7 MILLION VERSUS EUR 383,000 YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-03-29T00:16:00.000+03:00",
    "crawled": "2018-03-29T15:55:16.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "ose",
        "immunotherapeutics",
        "sa",
        "tedopi",
        "redeployment",
        "phase",
        "clinical",
        "phase",
        "early",
        "tedopi",
        "phase",
        "trial",
        "pancreatic",
        "cancer",
        "initiation",
        "expected",
        "entry",
        "clinical",
        "phase",
        "planned",
        "fy",
        "operating",
        "loss",
        "eur",
        "million",
        "versus",
        "profit",
        "eur",
        "million",
        "year",
        "ago",
        "fy",
        "net",
        "loss",
        "eur",
        "million",
        "versus",
        "profit",
        "eur",
        "million",
        "year",
        "ago",
        "cash",
        "available",
        "december",
        "eur",
        "million",
        "versus",
        "eur",
        "million",
        "year",
        "ago",
        "fy",
        "revenue",
        "eur",
        "million",
        "versus",
        "eur",
        "year",
        "ago",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}